… on the most important aspects currently recognized as key factors for the regulation of
nanomedicines, discussing the efforts under development by industry and regulatory agencies to …

… This process must be also carried out along with interagency harmonization efforts, to
support rational decisions pertaining to scientific and regulatory aspects, financing and market …

… This paper aims at reviewing the status and regulatory aspects of nano-based drug … )
regulations. In addition to discussing the ris s accompanied by the development of nanomedicine, …

… enable a harmonized global regulatory framework founded on … aspects. It considers whether
a legal metrology framework (LMF) needs to be developed for NT, including nanomedicine …

… nanomedicines by collaborating with various organizations in the EU enabling a platform for
both scientific and regulatory aspects. … at an early stage of nanomedicines development and …

… Indeed, the current regulatory framework has proved to be sound enough until now. A first
generation of nanomedicines (nanopharmaceuticals) got access to the market in a regulated …

… Nanomedicine, which involves the use of nanotechnology in drug development, offers ever
… The difference between nanomedicine and conventional drugs is that nanomedicine is …

… uncertainty and the lack of criteria for manufacturers, nanomedicines often end clinical …
evaluating nanomedicines and that analysing them on a case-by-case basis, based on …

… While there are many international initiatives to harmonize the regulatory …
nanopharmaceuticals, and developments process with strategies tailored to upcoming regulations …

… Accompanying document to the communication from the commission to the parliament,
the council and the european economic and social committee-regulatory aspects of …